The biological safety cabinet is commonly employed 
Introduction
Biological Safety Cabinets (BSCs) are employed in a multitude of clinical, research, and industrial applications, including blood, bioaerosol, and wastewater sample analysis, immunology, cell culture, and microbiology. In such work, reproducibility and the prevention of contamination are paramount to useable outcomes. The BSC is designed to achieve these goals by filtering and controlling the flow of air over objects contained within (U.S. Department of Health and Human Services 2007a, 2007b) .
BSCs were developed to protect contained materials and samples ("product") from contamination arising outside of the cabinet, from cross-contamination, and to protect the user from materials within (Stimpfel & Gershey, 1991) . This is achieved primarily through 3 controls, the High Efficiency Particulate Air (HEPA) supply/ exhaust filters, unidirectional flow of the air internally, and inward air flow at the front entrance to the cabinet. The prevention of contamination between samples is intended to result from the unidirectional downward flow of the air within the work area (Heinsohn et al., 1995) . The Class II, Type A safety cabinet typified by this study is frequently employed and is detailed in Figure 1 . In this type of cabinet air that has been HEPA filtered is pushed through an overhead diffuser into the cabinet workspace. As the air hits the work space it is split and collected by air returns at both the front and rear of the cabinet work area. At the front air intake, contaminated air from the room also enters and is pulled down in to the plenum of the cabinet. Air is then HEPA filtered before entering the work space via the overhead filter, thereby protecting cabinet contents from external contaminants. This intake of air at the front portal also functions to provide personnel protection by preventing cabinet air release outward through this air curtain. Class II, Type A cabinets typically vent the exhaust air directly into the room through a second HEPA filter on top of the unit. In this manner the indoor environment is protected from any aerosols released by procedures in the cabinet.
The Class II, Type A is manufactured by several companies and is anecdotally considered the most commonly encountered BSC. Regardless of the make all similar class/type cabinets operate under the same design parameters. These are prescribed by NSF International in NSF/ANSI Standard 49 (NSF, 2008) . In this type of cabinet approximately 70% of the air contained within has been recycled through the supply filter and about 30% comes in through the intake at the front. The specifications include the front sash height and opening size, the amount of air recirculated in the cabinet, and the intake velocity at the front, among other requirements (Heinsohn et al., 1995) . NSF 49 covers not only construction and design specifications, but also the verification methods for examining user and product contamination protection. Neither protection of the user nor sample cross-contamination is quantitatively assessed by the current NSF 49 field certification protocol. NSF 49 field tests include air flow velocity and HEPA filter integrity but a field method to determine actual bioaerosol mobility would be of value.
Different aerosol types are generated by many methods during routine sample and culture handling. Pipetting is one of the common sources of smaller aerosols, (Gerhardt, 1994) and it has been shown that up to 15,000 particles can be released when the residual contents in a pipette are forcibly expelled (Heinsohn et al., 1995) . Aerosols are created when a pipette is used to mix a liquid by "bubbling" that liquid, as bursting bubbles are known to release droplets into the air. The simple but routine action of opening containers also has the potential to generate aerosols. These droplets are generated when some of the fluid within the container has come in contact with the cap or plug. As the container is opened the surface tension holding the fluid between the container and cap by is broken, releasing droplets (Gerhardt, 1994) .
Mixing fluids by shaking is another source of aerosol generation, especially larger particles. As a hot needle or sterile loop is inserted into an agar or liquid media aerosols are released by the associated spattering. Similarly, sterilizing an inoculating loop also has the potential to create an aerosol by the same means. Inoculating rough agar with a loop or needle also results in the production of an aerosol, which is created by the loop or needle vibrating over the rough surface. Water from condensation in Petri dishes can also generate an aerosol, as happens when the film between the inverted dish and the rim of the lid is broken upon opening (Gerhardt, 1994) .
Centrifugation can cause foaming which has the potential of moistening the cap or other closure. Breaking that moisture film upon opening will yield an aerosol (Gerhardt, 1994) . Also, the foam bubbles may burst after the cap is removed. Predictably, droplets created when opening containers increase the risk of contaminating locations proximal to their creation, including the workspace or the user's hands (Stimpfel & Gershey, 1991) . In all of these scenarios the unidirectional airflow of the BSC is intended to serve as a primary means of control.
There are several benefits to using a polymerase chain reaction (PCR)-based "release and recover" method of testing a biological safety cabinet. It is known that even a single copy of a gene (and by extension, single bacteria harboring that gene) can be amplified to a million copies through the use of PCR (Gerhardt, 1994) . The PCR process therefore has a low limit of detection, and is therefore very sensitive, potentially highly accurate and discriminatory, and relatively quick as a method to confirm the presence or absence of a particular segment of DNA in a sample (Alvarez et al., 1995) . Also, in situ testing can be performed with a release and recover approach, actually testing the functionality of a specific Articles cabinet for performance relative to the equipment it contains. Such in-use performance testing has considerable merit when used in conjunction with the testing of basic design, performance and specification elements for such user devices. Finally, the method allows for a wide variety of user-specific processes, germane to actual contamination or process QA/QC issues at-hand. In this study genetically altered E. coli colonies recovered from Kanamycin containing agar impaction plates were analyzed via PCR to confirm that the colony forming units (CFUs) collected originated solely at the point of aerosol release, for a given set of experimental conditions tested. Examined in this study were: 1) the amount of cross-contamination occurring within the cabinet, and 2) the loss of containment from the cabinet to surrounding workspace, potentially contaminating other samples and equipment.
Methods
A Nuaire model NU-425-400 (Nuaire, Plymouth, MN) Class II, Type A Biological Safety Cabinet was used throughout this project. Annual certification of this type of cabinet is required and was accomplished prior to the sampling protocol (U.S. Department of Health and Human Services, 2007a , 2007b . In addition to airflow assessment, filter integrity was checked with an aerosol of poly Ơ-olefin (PAO, LCS Inc., 2003) . This aerosol was pumped directly into the front intake manifold, and a photometer used to scan the top diffuser, directly below the HEPA supply filter, as well as the HEPA exhaust filter. It should be pointed out that the introduction of PAO was not accomplished via a "T" connection from the supply line, and that the diffuser was not removed by the certification contractor. Both of these deviations from NSF 49 practices are not believed to have affected the final certification determination for the cabinet, however.
Release Aerosol
To enable the specificity of the new method, a novel test organism for release in a challenge aerosol was needed. Novel bacterial plasmids previously created and inserted into E. coli were utilized for this purpose (Coschigano & Bishop, 2004) . Briefly, the pCR-Blunt II-TOPO plasmid is part of the Zero Blunt TOPO PCR Cloning Kit (Invitrogen, Carlsbad, CA) . This kit allows for high efficiency direct insertion PCR products that have blunt ends (Invitrogen, 2004) . At each end of the open plasmid there is a topoisomerase I enzyme that is able to ligate double stranded (ds) DNA into the plasmid (Shuman, 1991) . In this way a circular dsDNA plasmid can be opened and the ends activated, to ligate to another strand of dsDNA (Shuman, 1994) . Within the plasmid are several genes that allow for selection of only those bacteria that contain the insert (Bernard et al., 1994) . Two inserts were used in this study, from the tutE and tutH genes of the tutE tutFDGH gene cluster in Thauera aromatic Strain T1. These genes have been well studied and cataloged (Coschigano & Bishop, 2004) .
E. coli suspensions containing the plasmid with the tutE insert were used in all challenge releases as well as for positive controls. Those with the tutH insert were used for negative controls. Cells containing the plasmid and inserts therefore exhibited two important characteristics making them well suited for use as challenge aerosol organisms. Firstly, the plasmid conferred a unique and easily assayed antibiotic (Kanamycin) resistance. Secondly, the plasmid allowed for a secondary confirmation of the recovered test bacteria through PCR. The tutE and tutH fragments differ in size from each other by over 500 base pairs (bp). This difference in size is easily resolved in agarose gels. Demonstrating the actual presence of plasmid/inserts was required to confirm that the source of the colonies recovered was exclusively from the aerosol released, and not from ambient sources, preexisting cabinet contamination, or poor laboratory techniques.
Existing strains of the tutE and tutH transformed E. coli bacteria were used (Coschigano & Bishop, 2004) . Bacterial cultures were passed to new plates at two week intervals to keep cells viable and maintain cell lines. Cultures for aerosolization as well as bacterial counting controls were grown in Luria-Bertani (LB) broth suspensions. Millers LB Broth Base (Life Technologies, Paisley, Scotland) was used to grow cells for eventual aerosol preparation, and as growth media in the agar impactor plates. LB media was made by mixing 25 g of dry LB powder into 1 L of deionized and filter sterilized water (dH2O), then autoclaved at 121°C for 20 minutes. After cooling to about 40°C the media was supplemented with Kanamycin (Boehringer, Mannheim, GmbH, Germany). To generate the broth culture for aerosolization a single viable colony was picked from an agar plate of stock bacteria colonies and placed in a sterile 15 ml test tube containing 3 ml LB broth. This was placed in a shaking incubator at 230 RPM and 37°C and left overnight. The following day the culture was removed from the incubator, the suspension brought to 25 ml total volume with LB Broth Base, and returned to the shaking incubator for about 3 hours prior to use for creating the challenge aerosol.
To initially determine the optimal time to grow the 25 ml cultures for aerosolization, incubator samples were taken from 0 minutes to 4 hours. Each sample was serially diluted and spread onto plates for enumeration. An aliquot was read for optical density (OD) at 550 nm using a Carey 50 Probe UV-Visible Spectrophotometer (Varian Inc., Palo Alto, CA). The use of OD at a given wavelength for the determination of bacterial concentration is standard microbiological practice (Hu et al., 2000) . OD readings, in conjunction with serial plate counts, provided a known growth time necessary for the LB broth culture to provide a sufficient concentration of bacteria for the challenge testing. To generate a robust challenge culture it was found that the cultures needed to grow for at least 3 hours in the shaking incubator at 37°C (data not shown).
The bacterial suspension concentration (E. coli/ml of suspension) was determined for each set of release/ recovery runs via serial dilution. From those data it was calculated that there was an average of 2.13 x 10 10 E. coli/ml of nebulizer stock (range: 1.40 x 10 7 to 9.50 x 10 10 ). Because the entire E. coli suspension was nebulized in each test run, the actual number of bacteria released in the cabinet for each run was known to within an order of magnitude. Concentrations were similar to those of Hu et al. (2000) and Ding and Wang (1997) in their studies involving the generation of viable bacterial aerosols. It should be appreciated that while viable cells and spores are known to be prone to damage via the nebulization process, the method discussed here is also based on the recovery of a cell fragment (i.e., the tutE or tutH genes) and its subsequent amplification via PCR. Accordingly, this semi-quantitative approach is less dependent on specific nebulizer types and release rates than it is on quality control related to PCR. The precise relationship between recoverable colonies on the aerosol sampler relative to "no hit" holes positive for the tutE gene was beyond the scope of this preliminary work.
After growth in 25 ml of LB broth the bacteria were harvested for nebulization. The bacterial suspension was moved to a centrifuge tube and spun at 4355 RCF (xg) (6000 RPM) for 10 minutes in an Avanti-J25 centrifuge (Beckman-Coulter, Fullerton, CA). The supernatant was discarded and the resultant bacteria pellet was suspended in 5 ml of phosphate buffered saline (PBS). PBS allows suspension of the cells in an aqueous solution that has been pH and ionically adjusted to maintain cell integrity (Hu et al., 2000) . The PBS had been filter sterilized with a Corning 0.20 µM Sterile Syringe Filter (VWR, Westchester, PA). For each set of experimental runs a sample of the bacterial suspension was serial diluted, spread onto LB agar plates, and enumerated after 2 days of growth; the remainder was used for the release experiments that day.
Both Ding and Wang (1997) and Ranalli et al. (2000) have shown that E. coli can be successfully aerosolized with a nebulizer and remain highly viable for sampling. Recovery rates of 63-91 percent were reported depending on the type of aerosol sampler employed (Ranalli et al., 2000) , implying that the Collison nebulizer they employed was capable of producing viable aerosols with as little as 10% loss from the stock concentration (average of 80% [79.5%] for all methods, all samplers tested; data not shown). Several methods of bioaerosol generation were available, and Willeke et al. (1996) have demonstrated that the specific method of aerosolization, as opposed to the agent being used, is not usually critical with regards to the viability and collection of the aerosol particulates. The CompAir XL Compressor Nebulizer System, Model NE-C18 (Omron, Vernon Hills, IL) was used for all release experiments. According to the manufacturer, the nebulizer operates at 30 to 36 psi, releasing on average 6 liters per minute of aerosol. The pressure and flow generated by the self-contained nebulizer-pump were not measured although the operation of this FDA-regulated medical device was visually verified. The nebulizer generates particles from 0.5 to 5 mm in physical diameter, a range that includes most viable environmental contaminants of interest (nano particles and viruses excepted). The nebulizer was activated remotely while located in the BSC, and was cleaned with 70% ethyl alcohol between runs.
The bacterial aerosol was always generated at the same central point of the cabinet work surface ( Figure  2 ). The outlet of the device was approximately 15 cm above the work surface and centered within the cabinet both laterally and from front to back. By this placement the aerosol was generated within the normal usage area in the cabinet but directed toward the cabinet front. Because the nebulizer expelled the entire 1 ml of bacterial suspension it contained in 1 minute, the bioaerosol samplers were started ahead of, and stopped after, nebulizer operation so as to encompass the entire release period.
Aerosol Recovery
An array of 3 single-stage (N-6) bioaerosol impactors (Aerotech 6, Phoenix, AZ) was typically used for aerosol recovery. This sampling technology was first described by Andersen in 1958 and is employed essentially unchanged in the samplers utilized (Andersen, 1958) . In use, each sampler pump was set to a flow rate of 28.3 liters of air per minute as indicated on the integral rotameter/flow controller, providing a sampling rate equivalent to the 1 cubic foot of air per minute design specification for the original Andersen sampler. Because the pumps for the samplers were located in the same room as the samplers, aerosols not trapped by the impactor could potentially be vented directly into the room, thereby resulting in erroneously high results. To prevent such contamination 0.2 µm Pall filters (VWR, West Chester, PA) were attached to each pump exhaust.
Sterile media plates used in the bioaerosol samplers were prepared in the authors' laboratory. Each plate consisted of a 100 mm x 15 mm sterile polystyrene Petri dish (Fisher Scientific, Pittsburgh, PA) containing exactly 36 ml of LB agar. That volume of agar resulted in the appropriate agar height required by the design of the sampler for the specified collection efficiency of particles in the N-6 size range (Andersen, 1958) . Prior to and after each run the cabinet and surfaces were thoroughly cleaned. Surfaces were sprayed with 70% ethanol and the cabinet was allowed to run for 1 hour between runs with the UV lamp on. After the UV exposure period but prior to any aerosol release, negative controls were collected by sampling the air in the same manner and at the same locations as would be used for the subsequent challenge release. The nebulizer was not running and no bacteria were released during this sampling.
Before each experimental run, a negative control sample (i.e., no aerosol nebulized) was collected under the same conditions and identical locations used in the experimental runs. All negative controls showed no growth (n = 24), demonstrating that the methods used to clean the cabinet between runs were effective, that the laboratory and cabinet were free of airborne recombinant E. coli contamination, and that the colonies recovered during the experimental runs originated solely from the test aerosols generated. A positive control was also run for each experimental challenge. For the positive control runs, all plates (n = 24) grew over 300 colonies of the Kanamycin-resistant bacteria (i.e., colonies were found under each of the sampler's 300 holes). As viable bacteria are drawn though the holes multiple CFUs going through the same hole will cause colony masking, such that 1 colony recovered may in fact have been the result of several impacting the plate beneath a given hole. Positive hole correction is therefore necessary, as detailed by Andersen (1958) . A positive hole count of 300 colonies corresponds to a corrected particle count of 555+ colonies, corresponding to an aerosol concentration of > 9.91 x 10 3 E. coli/m 3 . At these high numbers, the corrected count is therefore a minimum estimate of the total colony forming units present.
Samplers were placed at 1 of 4 locations for release and recovery experiments. The first location, used as a control for all runs, was directly in front of and under the aerosol plume generated from the nebulizer. The second and third locations were to the left and right of the center work space in the cabinet, 30 cm from the center where the aerosol was generated, and equidistant from the front grill and back wall. This distance was within the normal workspace of the cabinet but not close enough to the walls so as to be out of the area normally used by cabinet operators. The fourth location was outside the cabinet, on a stand in front of the front opening of the cabinet on the center line, directly in front of the nebulizer, 20 cm from the front sash of the cabinet and 5 cm below the work surface of the cabinet.
After aerosol recovery, plates were incubated for 2 days and results determined. Concentrations were calculated by counting the colonies found on the sample plates, applying the positive hole correction, dividing the total volume of air sampled and averaging for all replicates (Equation 1). After counting colonies, 3 colonies on each plate were randomly selected for definitive identification by PCR.
PCR Quantitation
The primers used for all experimental and control runs were the M13 Forward (TOP-MR) and M13 Reverse (TOP-MF) primers (IDT, Coralville, IA). The TOP-MR primer sequence is 5'-CAG GAA ACA GCT ATG AC and the TOP-MF primer sequence is 5'-GTA AAA CGA CCAA C. These were supplied as dried powders and dissolved in PCR grade dH2O (PCR-dH2O) (Qiagen Scientific, Valencia, CA) to a concentration of 2 µM. The 10 X reaction buffer used was ThermoPol Buffer (New England Biolabs, Ipswich, MA) and was supplied with the Taq polymerase (Taq DNA polymerase is the enzyme responsible for replicating the DNA). The stock dNTP solution contained 10 mM of each of the four dNTPs: dATP, dCTP, dGTP, and dTTP (Invitrogen, Carlsbad, CA) . All stock and intermediate dilutions of PCR reagents were kept at -20°C between uses. To avoid fractionalization, solutions were thawed at room temperature out of direct sunlight and refrozen by placing directly into the -20°C freezer. Positive controls confirmed the functionality of all reagents.
The time and temperature of each PCR step was the same for each experimental run and every control run. All PCR runs were conducted in a PTC-100 Programmable Thermal Controller (MJ Research Inc., Watertown, MA). Briefly, the first step in the reaction was for 2 minutes at 95°C, to lyse the bacteria and melt apart dsDNA, forming the ssDNA necessary to allow subsequent binding of primers and enzymes. The second step, significant only after the first full cycle (e.g., following
Step 5), was 30 seconds at 95°C. The third step was for 30 seconds at 49°C, the optimal temperature at which these primers bind. In the fourth step (1 minute at 72°C), primers were extended. The fifth step was a return to 95°C for 30 seconds, or Step 2. The cycle was repeated 29 more times for a total of 30 cycles. After the thirtieth cycling the reaction progressed to Step 6, a final primer extension step at 72°C.
Step 6 was run for 7 minutes to ensure all primers (and any strands only partially extended in previous cycles) were completely extended. At the conclusion of Step 6 the PCR machine cooled the reactions to 4°C, concluding the amplification process.
As an internal check, PCR was run on the TOPO plasmid containing the previously ligated tutE insert. The fragment produced from that PCR run was 447 bp long. PCR was run both on this plasmid in solution, as a control, and in viable bacteria. These controls are found as Lane 1 and Lane 4, respectively, in Figure 3 . The band in Lane 1 is slightly smaller than the 500 bp band seen in the 100 bp ladder lane, Lane 2. This is consistent with the expected size of a PCR amplified segment of 447 bp. The difference in fluorescent intensity between Lane 1 and Lane 4 is expected and not uncommon. Lane 3, a negative control, was identical to other lanes except that no DNA was added to the reagents for PCR. The fragment produced from PCR run on the bacteria containing the tutH insert in the TOPO plasmid was expected to be 1093 bp long. The size was confirmed by PCR and can be found in Lane 5 on the gel in Figure 3 .
After PCR the amplified gene sample was run on a gel for viewing and confirmation. An appropriate volume of concentrated loading dye (Promega, Madison, WI) was added to each PCR tube. The PCR product was then loaded into wells in a 1%/1%, wt/wt, Metaphore Agarose (Bio Whittaker Molecular Applications, Rockland, ME)/ Agarose gel (Low Electroendosmosis Agarose, National Diagnostics, Atlanta, GA). Per standard protocols 1% wt/ vol Metaphor Agarose and 1% wt/vol Agarose gel mix was made in 200 ml batches, to which 10 ml 1% ethidium bromide (Fisher Scientific, Pittsburgh, PA) was added. Each PCR reaction product was 20 µl, and after the reactions the volume was adjusted to 24 µl with loading dye. Of that 24 µl, 8 µl were typically loaded into a well for electrophoresis. Gels were allowed to run at 60 volts Figure 3 PCR Controls Lane 1 is the positive control from the plasmid and tutE insert. Lane 2 is the base pair size marker; smaller fragments move more quickly through the gel and are found lower. Lane 3 is a negative gel control (no DNA). The faint band in Lane 4 indicates the typical limit of detection with PCR, and shows the bacterial positive control. Lane 5 is a negative control from bacteria with only the larger tutH insert. Lane 6 is from a recovered bacterial bioaerosol colony.
for approximately 90 minutes in running buffer using a Power Pac 300 power supply (Bio-Rad Laboratories, Hercules, CA). Gels were viewed in a Bio-Rad Universal Hood with live video feed (Bio-Rad Laboratories, Segrate, Milan, Italy) using the Bio-Rad "Quantity One" software package (Bio-Rad Laboratories, Hercules, CA). Images were captured with the manual exposure setting adjusted for maximum separation of bands from background. Several internal PCR controls were included in the electrophoresis gels to confirm that the experimental bands produced were from the tutE insert. Those PCR controls included plasmid DNA in solution, negative and positive control bacteria as well as a blank (PCR reagent only) negative control lane (Figure 3 ). For each gel run, a negative and a positive bacterial control was also included. Those controls were consistently found in nine replicates. PCR was run on the purified plasmid containing the tutE insert. The expected band is found in Lane 1. Lane 3 is the result of the first negative control experiment. Lane 4 is a positive control from the original bacterial stock. Lane 5 is from PCR run on bacteria transformed with the tutH insert. (This lane functioned as both a negative and positive control, since this strain contains no tutE DNA and therefore should have shown no band at or near 447 bp.) Lane 5 functioned as a positive control for the primers, TOP-MR and TOP-MF. The PCR product in Lane 5 was expected to be slightly above the 1000 bp marker band, and those expectations were confirmed. The size differences of these bands allow for excellent discrimination. Lane 6 illustrates a positive control from one of the aerosol release experiments.
After the E. coli/m 3 concentrations were quantified from the aerosols impacted onto the plates, PCR was performed confirming that recovered colonies resulted exclusively from the test aerosol released and not from other sources. A representative gel showing experimental recovery runs, Lanes 6-13, is reproduced in Figure 4 . Randomly selected colonies from the bioaerosol recovery plates from each sampling location were subjected to PCR evaluation. Up to 3 colonies, when present, were tested from each plate. PCR confirmed that the plasmid in the original bacteria released in the cabinet was the same as that found on the bioaerosol plates. For the positive control plates, where the number of colonies was always > 300, this resulted in a sampling rate of only 1%. Such sampling was deemed appropriate given the consistent appearance of colonies on such plates.
Results

Limits of Detection
Since the nebulizer generates ~6 L of aerosol per minute, effectively turning 1 ml of the bacterial challenge agent into 6 L of air containing that suspension in particulate form the challenge aerosol was easily estimated. The average concentration of bacteria for each challenge was 1.70 x 10 10 E. coli/ml (as determined by OD and serial dilution plate counting), or 2.84 x 10 9
Figure 4
Representative Electrophoresis Gel Lane 1 is a positive control from DNA in solution. Lane 2 is the base pair size marker. Lane 3 is a DNA-free (negative) control. Lanes 4 and 5 are a positive and negative control, respectively, from stock bacteria. Lanes 6 through 11 are from colonies recovered directly below the nebulizer. Lanes 12 and 13 are from separate colonies recovered from a bioaerosol sampler outside the hood (blower off).
E. coli/L, and 2.84 x 10 12 E. coli/m 3 in aerosol form. These values include an estimated 20% reduction in E. coli collection efficiency based on the data of Rinalli et al. (2000) . This downward correction was applied to account for decreased E. coli viability resulting from the nebulization process, as well as drying effects related to evaporation throughout the process. Colonies counted during aerosol recovery can be expressed as E. coli per cubic meter (m 3 ) of air. Equation 1 was used to determine this concentration. Terms in Equation 1 include the "#CFUs," the colony count from each plate for a given run adjusted by the positive hole correction. The "L/min [flow rate]" was 28 L/min and "(sampling time-min)" was the sampling time (2 minutes for all runs). The final answer, in CFU/m 3 , describes the number of E. coli found in 1 cubic meter of air. The total CFU counts from the center sampling location during cabinet operation were calculated using Equation 1, after application of the positive hole correction (Table 1.) With the cabinet off, the concentrations recovered averaged > 9.91 x 10 3 E. coli/m 3 , but with the cabinet operating only 0.89 E. coli/m 3 were recovered on average (3 trials). This value represented the lower limit of detection as empirically determined. The upper limit of detection in this study was therefore 9.91 x 10 3 E. coli/ m 3 which represented aerosol sampling plates of > 300 colonies (and > 555 CFUs based on the positive hole correction). The concentration recovered divided by the concentration released results in the method sensitivity of 2.52 x 10 -13 E. coli/m 3 . These data demonstrate in an applied sense that an operational, properly functioning BSC results in an actual aerosol reduction of approximately 13 orders of magnitude (10 12 E. Coli/m 3 o 0.89
For every release experiment a positive control sample plate located directly under the point of aerosol generation was collected. As expected, those plates all showed the maximal growth of greater than 300 colonies. From each of these positive recovery plates 3 colonies (1%) were subjected to PCR analysis. Lane 6 on Figure 3 is the result of that PCR on the first positive control plate. Notice that the size of band produced from that first control colony is the same size in bp as the positive controls on that gel, Lanes 1 and 4. The positive result from Lane 3 demonstrated that the bacteria could successfully be aerosolized, collected and confirmed as the original test bacteria through PCR. On each gel (n = 8) both a negative and positive control were run, as well as the base pair markers.
Since N-6 bioaerosol plate media were inhibited with Kanamycin, and negative controls ruled out the presence of other bacteria, any colony growth is conclusively known to be the result of the genetically modified bacteria alone. PCR was run to confirm these expectations, and each run condition and location was accompanied by at least 3 such control replicates.
Cross-contamination
As anticipated, internal cross-contamination was largely a function of whether the cabinet was on or off. The center location consistently showed 300+ colonies, or greater than 555 CFUs after positive hole correction, with the cabinet either on or off. Samplers set up 30 cm to the left and right of the center of the workspace showed results entirely dependent on the cabinet being on or off. With the cabinet off the lateral locations produced greater than 555 E. coli per plate for every run. With the cabinet operating the E. coli count was dramatically lower with side locations producing only a total of 3 E. coli colonies in all 3 replicate runs.
The extent of lateral bioaerosol migration within the cabinet was less than a single bacterium (0.89 E. coli/ m 3 ) as reported in the average of the E. coli/m 3 from both the right and left samplers.
Containment
Sampling outside of the cabinet was done to examine and quantitate the escape of viable aerosol. Although there is no expectation a Class II, Type A BSC is 100% effective for containment, results demonstrated zero (0) E. coli released while the cabinet was running. This was not unexpected in that the NSF method purposely introduces an airflow disruption in order to produce non-zero results. Nevertheless, the PCR technique allowed an empirical observation of the actual degree of such control under in situ conditions. All plates used for sampling outside of the cabinet either had no colonies (cabinet on), or greater than 300 (cabinet off). Figure 5 , Lanes 2-3 and 18-21 show the results of PCR on the colonies selected from samplers outside the cabinet (cabinet off). These results demonstrate the ability to recover bacteria that were aerosolized inside the cabinet once they have migrated to the cabinet exterior, as well as show good experimental hygiene with respect to the aerosolized DNA from previous experimental runs.
The positive and negative bioaerosol plate controls were also confirmed with PCR. All negative controls had no (zero) growth, while each positive control plate had over 300 colonies. All colonies selected for PCR showed a positive band for the expected genetic insert. A positive control plate was run for each experimental condition. A selection of those PCR results for both the cabinet on and the cabinet off conditions are found in Lanes 6-11 in Figure 3 , and Lanes 4-7, 14, 18-22 in Figure 5 .
All PCR results showed a positive band except for the negative controls. Including the control runs, there were 75 PCR runs conducted to verify bioaerosol colony identities. Twenty of the 75 runs are presented in Figure  5 , shown on 2 gels runs simultaneously. PCR confirmed that the collected bacteria under all conditions and in all locations were in fact the recombinant E. coli released for each particular run. 
Discussion
From these results it is clear that a properly operating BSC does an excellent job of containing even extremely concentrated aerosols generated within. There were no bacteria recovered outside of the cabinet when the cabinet was running under normal, undisturbed operating conditions. The effect of operator movements, procedures, and equipment were not examined while developing this new assessment technique. Since inward airflow is critical to cabinet containment, and any operator effects would disturb that flow, releases under such conditions would be expected. With the sensitivity of this new method it is evident that any such releases related to operator effects could be detected. The crosscontamination findings, demonstrating detectable lateral migration even while the cabinet was on, affirm this assertion. PCR was found to be an excellent addition to simple bioaerosol counts for cabinet testing. The use of PCR with known primers and inserts, in conjunction with appropriate experimental controls, provided an excellent tool to demonstrate the movement of bacteria laterally within a BSC. Results demonstrated a cross-contamination potential of 0.6-1.2 E. coli/m 3 at the 30 cm distances examined (Table 1) . The percent reduction can be defined as the concentration of the bioaerosol sampled during the recovery sampling divided by the concentration collected during the positive control runs. Using the concentrations determined while the cabinet was off as the base line, the amount of lateral aerosol migration to both the right and left samplers showed an average of 9.91 x 10 3 E. coli/m 3 (3 replicates). While the cabinet was on identical sampling demonstrated an average of < 1 E. coli/m 3 detected (8.93 x 10 -1 E. coli/m 3 ). This concentration reduction was almost 5 orders of magnitude (e.g., an average 9.01 x 10 -3 percent reduction), which roughly agrees with the minimum 4 orders of magnitude reduction required in NSF 49. This percentage drop more accurately demonstrates the cabinet's ability to limit crosscontamination under these conditions, and represents a new metric of interest to many BSC users. Furthermore, this specific test is markedly more meaningful than the assessment of unidirectional flow performed during normal NSF 49 style field testing. Using PCR to confirm that the bacteria recovered were the same as released, in conjunction with the simultaneous use of conventional air sampling techniques to enumerate that movement, was consistent with the expectation that internal cabinet contamination is likely even under the best (i.e., undisturbed) of circumstances. With the added problems from operator effects, such cross-contamination presents the greatest overall risk both internally and externally (through transferable operator or equipment contamination). Aerosol containment under usual BSC use conditions and procedural manipulations was not examined. Nor was the performance of the BSC after certain higher risk release events, such as filter changes, blower repairs, spills, power loss, or cabinet relocation. Such considerations are highly relevant to future studies.
This work introduces the possibility of testing kits for in situ BSC evaluations by suitably qualified end users. Many equipment requirements for the utilization of such a kit typically exist in many BSC-equipped laboratories, and could easily be applied to this in situ testing. In this regard end users would only need to purchase or rent the missing components. In this way end users would be able to assay their BSCs as their own schedule allowed and in a way that had increased accuracy and sensitivity over current field tests. Perhaps of most significance, focused studies to determine recalcitrant contamination problems could also be conducted to improve production, quality control or both.
Data demonstrate that the BSC can produce an aerosol reduction of up to 13 orders of magnitude in the lateral motion of a particulate under ideal conditions. This is much higher than the NSF microbial aerosol challenge method which produces 8 orders of magnitude difference for the personnel protection test and 4 orders for the cross-contamination test. Possible explanations for this higher sensitivity include our use of a different test procedure involving different release and collection locations, and our testing under ideal circumstances, including closed room door and no intentional disruption of the inward room airflow to the cabinet (Figure 1 "A") . While this sensitivity may in fact not be required for routine manipulations or agents of lower biosafety level (1), its utility might best be realized in the study and assignment of biosafety levels to new agents or new equipment. Such low limits of detectability as demonstrated here (~1 E. coli/m 3 ) could also be very useful in training new BSC operators in good technique and practices. Furthermore, an entirely new area of research is now available given the sensitivity of the novel technique. Quantitative risk assessments are now readily and safely possible to better determine and describe release potentials related to traditional microbiological applications as well as new methods or equipment.
Conclusions
The primary aim of this study was to explore the feasibility of a more discriminatory test of the BSC (relative to the field tests specified in NSF 49 Annex F). This was accomplished by combining traditional bioaerosol sampling with the sensitivity and accuracy permitted by PCR on specific recombinant bacterial genes. This tested the extent to which a biological safety cabinet was able to control and contain a true bioaerosol under in situ conditions (as it is primarily designed to do). The creation of a novel experimental test for BSCs was also achieved, in which was demonstrated the effectiveness of using PCR in conjunction with conventional air sampling methods. In conducting this research it was shown that: a. A properly functioning biological safety cabinet was able to control the egress of a bioaerosol to within 13 orders of magnitude under steady-state conditions. b. The reduction of lateral motion of an E. coli aerosol by a Class II, Type A BSC is approximately 5 orders of magnitude, a result confirming this ability of BSCs. The BSC tested was unable to fully prevent lateral motion of a particulate under the conditions tested. c. PCR can be used to compliment conventional NSF 49 field testing techniques with an aerosolized challenge of viable bacteria in order to create a quantitative assay and useful in situ test method for cabinet end users.
The applicability of such work is not restricted to the microbiological or biotechnology communities. Others who work with or must contend with small particle contaminants include microelectronics and nanotechnology www.absa.org Applied Biosafety Vol. 15, No. 4, 2010
Articles manufacturers, and all users of ISO (or older FS209) classified cleanrooms. In such settings this technique could be used, or adapted, for the conduct of additional studies using the E. coli aerosol as a surrogate for the actual particle of interest.
Future studies of this novel technique might examine the abilities of BSCs to prevent the ingress of particulates at the front portal when other than undisturbed, steady-state airflow conditions exist. Furthermore, it would be of great interest to further examine lateral migration of bioaerosols given users' arm movements. For example, a linear array of samplers abutting each other, moving away from the nebulizer and parallel to the front portal, could be used to better quantitate actual crosscontamination potential. Also of interest is the ability of the BSC to contain and control bioaerosols in the presence of routine laboratory cabinet use. Testing using the novel method might be repeated when equipment commonly used and stored within a BSC is present, such as pipettes, Bunsen burners, reagent bottles, etc. Additionally, the effect of the operator or an operator surrogate (i.e., a mannequin), could be used to examine the effects of arms changing the air patterns both at the front intake and within the cabinet, in conjunction with such operations. Finally, direct comparison of this method to the NSF 49 microbiological aerosol challenge test should be conducted in future work on its development or validation.
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